Peps
What is DSIP?
DSIP stands for delta sleep-inducing peptide. The name reflects its research history, while actual sleep outcomes require direct measurement.
Biological role or research focus
Experimental sleep regulation.
The name “sleep-inducing” is not proof of a meaningful improvement in chronic insomnia.
Role reference: Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. ↗
Names you may encounter
emideltide · delta sleep inducing peptide
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Experimental sleep-related peptide
- Main research area
- Sleep physiology
- Evidence featured
- Small blinded human study
- Source check
- October 4, 2026
Molecular structure
Mechanism & research rationale
DSIP has been examined as a modulator of sleep. Its name does not specify a clinically established mechanism or guarantee an effect on restorative sleep.
Research context & status
The selected insomnia experiment provides limited human evidence, with weak objective changes and no subjective sleep-quality benefit. It does not establish a routine treatment for chronic insomnia.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Small blinded human study · 1992
Chronic insomnia experiment
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.
- Population / model
- 16 people with chronic insomnia.
- Study design
- Matched-pairs parallel groups; five laboratory nights including baseline, followed by three treatment nights.
- Main finding
- Some objective sleep measures changed modestly, but subjective sleep quality did not improve. The authors considered major short-term therapeutic benefit unlikely.
- Limits & context
- The small sample, short duration, and partly placebo-driven differences limit confidence. The name “delta sleep-inducing peptide” is not itself evidence of an insomnia treatment.
Small human crossover study · 1981
DSIP · six-volunteer sleep experiment
How does an early sleep signal compare with the later insomnia trial?
- Population / model
- Six healthy volunteers, four men and two women.
- Study design
- Double-blind crossover experiment with placebo, short-term sleep monitoring, and subsequent-night measurements.
- Main finding
- Median total sleep time increased 59% within a 130-minute observation interval. Shorter sleep onset and improved sleep efficiency were reported for the following night.
- How to read it
- The percentage describes a short observation window, not a sustained increase in nightly sleep or successful treatment of chronic insomnia.
- Limits & context
- Six healthy participants and brief monitoring cannot establish long-term efficacy or uncommon harms. Read alongside the later 16-person insomnia study, which found limited benefit. Absence of observed side effects is not proof of safety.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Search additional PubMed records ↗New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety evidence & remaining uncertainty
FDA identifies a safety-data gap. The small sleep study cannot characterize uncommon adverse effects or repeated long-term exposure.
Source: FDA · Peptide compounding safety concerns ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
8 matching video records · 2 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Peptide Of The Week
Peptide of the Week: Epithalon & Glutathione – Longevity, Sleep & Detox ↗
Captions indexed · Automatic matches need review
Trevor Kruder
Episode 18: Peptide testing, sourcing, research, and regulation talk with Brande Roderick ↗
Captions indexed · Automatic matches need review
Biohackingturkey
Derin Uyku Formülü: DSIP Peptidi Nedir, Ne İşe Yarar? ↗
Title match · Captions not indexed
Biohackingturkey
DSIP Peptidi: Uyku Üzerindeki Etkileri Gerçekten Kanıtlandı mı? ↗
Title match · Captions not indexed
Dr. Jones, DC
Doctor Explains How DSIP Peptide Improves Sleep, Lowers Stress & More (DSIP Explained) ↗
Title match · Captions not indexed
Dr. Jones, DC
You're WASTING DSIP! Here's the Dosing Sweet Spot (Weight Loss Doctor Explains) ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
DSIP (Delta Sleep-Inducing Peptide) (5mg)
BioLongevity Labs · Vendor-labeled research use only
$55.97
Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
DSIP (5 mg)
American Peptides · Vendor-labeled research use only
$55.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
DSIP (5 mg / 10 mg)
PSPeptides · Vendor-labeled research use only
$39.99–$54.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- What specific product, route, and research population does the claim refer to?
- Does the source measure an outcome in people, or only a laboratory marker?
- The name “sleep-inducing” is not proof of a meaningful improvement in chronic insomnia.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Does “sleep-inducing” mean proven insomnia treatment?
No. A compound name can outlast the hypothesis that produced it. The controlled findings matter more.
Were participants simply asked whether they slept better?
The study used objective sleep recordings as well as subjective measures, and the two did not show a consistent benefit.
References & editorial record
- FDA · Compounding safety concerns ↗
- PubMed · Small double-blind human study · PMID 1299794 ↗
- DSIP · six-volunteer sleep experiment · 1981 ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.